Patent ID: 11864904
Assignee: MEDTRONIC IRELAND MANUFACTURING UNLIMITED COMPANY
Field: Medical technology (Instruments)
Classification: CPC A  G | IPC A  G

Claim 16:
17. A method comprising:
receiving, by a controller and from an optical magnetic sensor, a baseline measurement of a magnetic field generated by target nerves of a patient before delivery of neuromodulation treatment to a target site within the patient, wherein the baseline measurement includes at least one of a magnitude of the magnetic field, a distance from the optical magnetic sensor to one or more of the target nerves, a magnitude of impulses of the target nerves or a temporal extent of the impulses of the target nerves;
delivering the neuromodulation treatment to the target nerves;
after delivering the neuromodulation treatment, receiving, by the controller, a post-neuromodulation measurement of the magnetic field generated by the target nerves from the optical magnetic sensor, wherein the post-neuromodulation measurement includes the at least one of the magnitude of the magnetic field, the distance from the optical magnetic sensor to one or more of the target nerves, the magnitude of impulses of the target nerves, or the temporal extent of the impulses of the target nerves;
comparing, by the controller, the post-neuromodulation measurement to the baseline measurement; and
based on the comparison of the baseline measurement to the post-neuromodulation measurement, determining, by the controller, a percentage that the target nerves were ablated by delivering the neuromodulation energy.